17-27303368-C-G
Variant summary
Our verdict is Benign. Variant got -8 ACMG points: 0P and 8B. BP4_StrongBS2
The NM_015626.10(WSB1):āc.211C>Gā(p.Leu71Val) variant causes a missense, splice region change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000428 in 1,613,512 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 16/23 in silico tools predict a benign outcome for this variant. 3/3 splice prediction tools predict no significant impact on normal splicing. Variant has been reported in ClinVar as Uncertain significance (ā ).
Frequency
Consequence
NM_015626.10 missense, splice_region
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Benign. Variant got -8 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | UniProt |
---|---|---|---|---|---|---|---|
WSB1 | NM_015626.10 | c.211C>G | p.Leu71Val | missense_variant, splice_region_variant | 3/9 | ENST00000262394.7 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|
WSB1 | ENST00000262394.7 | c.211C>G | p.Leu71Val | missense_variant, splice_region_variant | 3/9 | 1 | NM_015626.10 | P1 |
Frequencies
GnomAD3 genomes AF: 0.000223 AC: 34AN: 152134Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.0000399 AC: 10AN: 250738Hom.: 0 AF XY: 0.0000443 AC XY: 6AN XY: 135578
GnomAD4 exome AF: 0.0000240 AC: 35AN: 1461260Hom.: 0 Cov.: 32 AF XY: 0.0000220 AC XY: 16AN XY: 726904
GnomAD4 genome AF: 0.000223 AC: 34AN: 152252Hom.: 0 Cov.: 32 AF XY: 0.000215 AC XY: 16AN XY: 74448
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Jan 16, 2024 | The c.211C>G (p.L71V) alteration is located in exon 3 (coding exon 3) of the WSB1 gene. This alteration results from a C to G substitution at nucleotide position 211, causing the leucine (L) at amino acid position 71 to be replaced by a valine (V). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at